Company Profile
 |
Athlomics Pty Ltd Athlomics Pty Ltd is commercialising a patented panel of biomarkers which can potentially be used as a point-of-care blood test for monitoring immune status and health in humans and animals. The company is also commercialising a blood test to distinguish between sepsis and systemic non-septic inflammation in human patients, particularly in immuno-compromised patients. Athlomics is conducting contract R&D using its proprietary technology for a US partner in the development of new immuno-stimulant products for horses. The company is being funded by its founding shareholders and is currently closing a seed round of equity financing to accelerate development. Keywords: human health, immune health, diagnostics, sepsis, status determination, ICU, emergency, prognostics, biomarkers, blood, pathology laboratories
Phone: 07 3870 2689 | Fax: 07 3870 2658
Biotechnology Categories
|